Pedro Henrique Sebe Rodrigues

Pedro Henrique Sebe Rodrigues

Auto-generated profile, based on publicly available information

Pedro Henrique Sebe Rodrigues

Genesis Genomics, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2024 in Materials Circular Economy
Verified
Journal Article
Closed access
PDF file
ESElvis da Cruz Santos
Elvis da Cruz Santos
ABAna Amelia Amélia Benedito-SIlva
Ana Amelia Amélia Benedito-SIlva
RFRegis Rossi Alves Faria
Regis Rossi Alves Faria
Márcia de Almeida RizzuttoMárcia de Almeida Rizzutto
Márcia de Almeida Rizzutto
PRPedro Henrique Sebe Rodrigues
Pedro Henrique Sebe Rodrigues
JBJulia Baruque-Ramos
Julia Baruque-Ramos

25 November 2021 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
João Renato Rebello PinhoJoão Renato Rebello Pinho
João Renato Rebello Pinho
KOKetti Gleyzer de Oliveira
Ketti Gleyzer de Oliveira
RSRoberta Sitnik
Roberta Sitnik
MMMaira Marranghello Maluf
Maira Marranghello Maluf
PRPedro Henrique Sebe Rodrigues
Pedro Henrique Sebe Rodrigues
OIOphir Irony
Ophir Irony
During the COVID-19 pandemic, a case of a long-term persistence of SARS-CoV-2 infection (from March 26 to May 20, 2020) was identified at a private hospital in São Paulo, SP, Brazil. The long-term positivity for SARS-CoV-2 in reverse transcriptase polymerase chain reaction tests of a patient diagnosed with COVID-19 suggests, at least part of patients who recovered, may still carry and transmit the SARS-CoV-2 virus. This fact emphasizes the importance of having at least two negative reverse transcriptase polymerase [...] ABSTRACT During the COVID-19 pandemic, a case of a long-term persistence of SARS-CoV-2 infection (from March 26 to May 20, 2020) was identified at a private hospital in São Paulo, SP, Brazil. The long-term positivity for SARS-CoV-2 in reverse transcriptase polymerase chain reaction tests of a patient diagnosed with COVID-19 suggests, at least part of patients who recovered, may still carry and transmit the SARS-CoV-2 virus. This fact emphasizes the importance of having at least two negative reverse transcriptase polymerase

1 January 2022 in Annals of Hepatology
Verified
Journal Article
Open access
PGPatrícia Oliveira Gionda
Patrícia Oliveira Gionda
MGMichele Gomes-Gouvea
Michele Gomes-Gouvea
FMFernanda de Mello Malta
Fernanda de Mello Malta
PSPedro Sebe
Pedro Sebe
ASAna Paula Moreira Salles
Ana Paula Moreira Salles
João Renato Rebello PinhoJoão Renato Rebello Pinho
João Renato Rebello Pinho
Hepatitis B Virus is classified into ten different genotypes (A- J). Genotypes F and H cluster apart from others in phylogenetic trees and is particularly frequent in the Americas. The aim of this study was to sequence complete genomes of samples of HBV genotypes F and H from Brazil and Mexico using next generation sequencing (NGS) and to study relevant characteristics for the disease associated with this virus. Ninety plasma samples with detectable HBV DNA belonging to the F (n=59) and H (n=31) genotypes were submitted to amplification of the complete HBV genome by three different methologies. Data analysis was developed using bioinformatics tools for quality assurance and comprehensive coverage of the genome. Sequences were aligned with reference sequences for subgenotyping and detecting variants in relevant positions. A phylogenetical tree was constructed using Bayesian methods. HBV genome of 31 samples were amplified and 18 of them were sequenced (HBV/F=16 and HBV/H=2). One genotype F sample was co-infected with the F1b and F3 subgenotypes, while the other samples were all F2a subgenotype. Two genotype H samples clustered with other Mexican sequences. The main variants observed were found in preS and S genes (7/18) and mutations in the precore/core region (11/18). A NGS methodology was applied to F and H genotypes samples from Mexico and Brazil to fully characterize their sequences. This methodology will be relevant for clinical and epidemiological studies of hepatitis B in Latin America.

18 June 2025 in Journal of Medical Virology
Verified
Journal Article
Open access
KOKetty Gleyzer de Oliveira
Ketty Gleyzer de Oliveira
MVMariana Pinheiro Alves Vasconcelos
Mariana Pinheiro Alves Vasconcelos
JTJulia Teixeira Ton
Julia Teixeira Ton
SUSilvia Naomi de Oliveira Uehara
Silvia Naomi de Oliveira Uehara
RSRoberta Sitnik
Roberta Sitnik
João Renato Rebello PinhoJoão Renato Rebello Pinho
João Renato Rebello Pinho
Hepatitis A Virus (HAV) infects millions of individuals annually and is a major cause of acute viral hepatitis worldwide. This study aims to (1) assess HAV infection in suspected acute hepatitis patients at public healthcare institutions in Brazil; (2) evaluate the proportion of immunized individuals against HAV; (3) identify HAV genotypes; (4) examine the association between HAV infection and demographic data, as well as exposure to risk factors. This is a prospective, observational multicenter study conducted in primary health services in Brazil from October 2019 to May 2023, involving 1721 patients with suspected acute hepatitis. Acute HAV infection was identified in 108 (6.3%) patients, predominantly in young men (80%) and from South and Southeast regions of Brazil (97%). Anti‐HAV IgG, indicating previous exposure or vaccination, was detected in 78.6% of individuals (74% in the South to 91% in the North). Genotype I.A was found in all cases and approximately 450 mutations were identified, most of them in the structural proteins VP1‐3. Two viral groups were identified and related to two introductions of the virus: cosmopolitan sequences from North America, South America, and Europe, and a minor group of Brazilian sequences similar to Asian and South American ones. The high incidence of acute HAV infections highlights the need for targeted prevention and vaccination strategies. The characterization of HAV genetic diversity and molecular epidemiology contributes to monitoring and identifying emerging outbreaks.

20 August 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
DADeyvid Amgarten
Deyvid Amgarten
FMFernanda Mello Malta
Fernanda Mello Malta
RFRaquel Riyuzo de Almeida Franco
Raquel Riyuzo de Almeida Franco
ABAna Laura Boechat
Ana Laura Boechat
ASAna Carolina dos Santos Soares
Ana Carolina dos Santos Soares
João Renato Rebello PinhoJoão Renato Rebello Pinho
João Renato Rebello Pinho
The airway microbial community may shape the variable outcomes of COVID-19, but its role is poorly understood. We profiled naso-oropharyngeal swab samples from 561 people using marker-gene amplicon sequencing, total-RNA metatranscriptomics, and shotgun DNA metagenomics, which together tracked SARS-CoV-2 lineages, detected respiratory co-infections, and recovered 190 microbial genomes including candidate previously undescribed species. Here we show that increasing COVID-19 severity is associated with a reproducible depletion of oral commensal bacteria — most consistently Gemella, with Rothia, Haemophilus and related genera — concordant across all three sequencing approaches and robust to sensitivity analyses, and accompanied by shifts in microbial metabolic and stress-response functions. In contrast, bacterial resistance-gene burden did not increase with antibiotic use or severity, host gene-expression changes were limited, and bacteria enriched in severely ill patients were largely environmental, consistent with low-biomass artifacts. These findings define a commensal-depletion signature of COVID-19 severity.

23 June 2026 in bioRxiv
Verified
Preprint
Open access
GSGabriel Do Nascimento Santos
Gabriel Do Nascimento Santos
PRPedro Henrique Sebe Rodrigues
Pedro Henrique Sebe Rodrigues
CPCarlos Henrique Passos
Carlos Henrique Passos
SPSamantha Lucciola Guedes Paco
Samantha Lucciola Guedes Paco
IIIsadora Bianchi Ignacio
Isadora Bianchi Ignacio
MNMichel Satya Naslavsky
Michel Satya Naslavsky
The APOE gene is a critical determinant of human healthspan and longevity, with the rare ϵ2 allele traditionally viewed as a universal protective factor against Alzheimer s disease (AD) and a driver of exceptional lifespan. However, this protective paradigm is predominantly derived from European-centric cohorts, leaving the evolutionary and clinical impacts of ϵ2 across diverse, highly admixed populations largely unknown due to a lack of local ancestry (LA) resolution. To investigate how local genomic backgrounds modulate APOE survival dynamics we analysed two Brazilian sample collection of older adults from Sao Paulo city: the Biobank for Aging Studies (BAS, n = 716), a post-mortem autopsy study of naturally deceased individuals; and the Health, Well-being and Aging Study (SABE, n = 952), a census-based elderly sample collection. We evaluated deviations from Hardy-Weinberg equilibrium (HWE) using robust permutation-based models to capture ongoing selective and mortality pressures at the APOE locus. While global APOE frequencies adhered to HWE, integrating LA unveiled striking, mirrored ancestral deviations. Our findings reveal that APOE ϵ2 homozygotes with African ancestry significantly contribute to deviations from HWE in the BAS, with an excess of ϵ2AFR/ϵ2AFR homozygotes observed (p = 0.0196). These distinct HWE deviations demonstrate that an African LA background acts as a genetic buffer, attenuating the phenotypic extreme effects of APOE alleles. Furthermore, we observed an excess of the ϵ4 European haplotypes in the BAS, which is consistent with a mortality pressure allelic effect in the European LA context. Conversely, the ϵ4AFR/ϵ4AFR combination was overrepresented in the SABE. While this buffering mechanism mitigates ϵ4 toxicity, it simultaneously dampens the exceptional longevity advantage typically conferred by the ϵ2 allele, leading to its neutral accumulation in the post-mortem cohort. Our study challenges the "one-size-fits-all" assumption of APOE biomarkers, demonstrating that ϵ2 protective mechanisms are context-dependent and modulated by local genomic backgrounds in admixed populations. pulations.